Evidence map›Paper›PMID 39893410›Full record

ArticleBMC musculoskeletal disorders2025

Serum choline, leptin and interleukin-6 levels in fibromyalgia syndrome-induced pain: a case-control study.

Elif Baris, Izel Topaloglu, Elif Akalin, Emre Hamurtekin, Seray Kabaran, Ayse Gelal, Reyhan Ucku, Mualla Aylin Arici

Abstract read
In one paragraph

Article in BMC musculoskeletal disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Elif BarisIzmir University of Economics, Faculty of Medicine, Department of Medical Pharmacology, Izmir, Turkey.
Izel TopalogluDokuz Eylul University Faculty of Medicine, Department of Physical Therapy and Rehabilitation, Izmir, Turkey.
Elif AkalinDokuz Eylul University Faculty of Medicine, Department of Physical Therapy and Rehabilitation, Izmir, Turkey.
Emre HamurtekinEastern Mediterranean University Faculty of Pharmacy Department of Pharmacology, Turkish Republic of Northern Cyprus, Turkey.
Seray KabaranEastern Mediterranean University Faculty of Health Sciences Department of Nutrition and Dietetics, Turkish Republic of Northern Cyprus, Turkey.
Ayse GelalDokuz Eylul University Faculty of Medicine, Department of Medical Pharmacology, Division of Clinical Pharmacology, Izmir, Turkey.
Reyhan UckuDokuz Eylul University, Faculty of Medicine, Department of Public Health, Izmir, Turkey.
Mualla Aylin AriciDokuz Eylul University Faculty of Medicine, Department of Medical Pharmacology, Division of Clinical Pharmacology, Izmir, Turkey. aylin.akgun@deu.edu.tr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFibromyalgia Syndrome (FMS) predominantly affects middle-aged women, characterized by musculoskeletal pain, fatigue, and cognitive issues. Choline, an endogenous molecule, may influence FMS due to its analgesic and anti-inflammatory properties. This study compared choline, leptin, and interleukin-6 (IL-6) levels in FMS patients and controls and examining their association with pain severity.

methodsVolunteers with FMS were clinically diagnosed at a Physical Medicine and Rehabilitation Department. The control group included pain-free volunteers. Pain severity was gauged using a numeric scale, dietary choline intake through a questionnaire. Serum choline, leptin and (interleukin)IL-6 levels were measured from fasting blood samples of volunteers with enzyme-linked immunosorbent assays (ELISA).

resultsAll FMS patients (n = 38) and healthy volunteers (n = 38) were female. Pain score in patients with FMS was 7.6 ± 0.2. Dietary choline intake was lower in patients with FMS than the controls (p = 0.036). Serum choline and leptin levels were lower in the FMS group compared to control (p = 0.03). Serum IL-6 levels were higher in the FMS group than in the control (p < 0.001). There was weak positive correlation between IL-6 levels and pain scores and there were no correlation between leptin levels and pain scores in FMS.

conclusionsThis research highlights FMS's complex nature, involving neurochemical, immunological, and nutritional factors. It suggests the significance of choline's anti-inflammatory effect, leptin's metabolic function, and IL-6's role in FMS pathology. The results suggest that reduced dietary choline might influence serum choline, leptin, and IL-6 levels, potentially impacting FMS-related pain. This points to the potential of supplementary choline intake in FMS management.

trial registrationNot applicable (Non-interventional study).

Indexed as

CholineFibromyalgiaInterleukin-6LeptinAdultBiomarkersCase-Control StudiesFemaleHumansMiddle AgedPain MeasurementBiomarkersCholineIL6 protein, humanInterleukin-6LEP protein, humanLeptinCholineFibromyalgiaInflammationInterleukin-6LeptinNutritionPain

Identifiers

PMID39893410
PMCPMC11786483

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.